Propanc Biopharma (PPCB)
(Delayed Data from OTC)
$2.87 USD
-0.11 (-3.69%)
Updated Aug 15, 2025 03:59 PM ET
After-Market: $3.29 +0.42 (14.63%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Propanc Biopharma Inc's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PPCB 2.87 -0.11(-3.69%)
Will PPCB be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PPCB based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PPCB
12 Health Care Stocks Moving In Friday's Intraday Session
U.S. IPO Weekly Recap: Bullish And Miami International Complete The Last Major IPOs Of The Summer
Propanc Biopharma opens at $4.00 in Nasdaq uplisting
12 Health Care Stocks Moving In Friday's After-Market Session
Propanc Biopharma announces Nasdaq uplisting